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ABSTRACT 
Background: Cadmium is an extremely toxic metal with ubiquitous environmental distribution. Cadmium is a potent 
reproductive and developmental toxic agent, and intensive environmental exposure to this substance has been 
reported among the residents of Tehran. In this study, we investigated the correlation between amniotic fluid cadmium 
levels and the risk of preeclampsia, prematurity and low birth weight. 
Methods: This study was conducted on 341 hospitalized pregnant women. Amniotic fluid samples were obtained during 
childbirth, prepared by acid digestion, and cadmium concentration was determined using atomic absorption 
spectrophotometer equipped with a graphite furnace. 
Results: In this study, the mean amniotic fluid cadmium concentration in non-smokers was significantly lower (780± 
0.231 µg/l) compared to smokers (13.4±0.91 µg/l). Increased amniotic fluid cadmium levels were associated with the 
reduction of birth weight, and birth weight was below 2500 g in all the cases with amniotic fluid cadmium levels of 
>15µg/l. Moreover, preeclampsia was more prevalent among smoking mothers compared to non-smokers. The total 
incidence rate of preeclampsia (12.6%) was significantly higher in this study compared to similar studies. In addition, 
no correlation was found between amniotic fluid cadmium levels and the rate of prematurity.  
Conclusion: According to the results of this study, cadmium levels of amniotic fluid could be used as sensitive and 
reliable biomarkers to monitor the reproductive and developmental toxicity of cadmium. 
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Introduction  
Cadmium is an extremely toxic metal, which is 
widely distributed in the environment. This 
pollutant has no natural sources, and millions of 
tons of cadmium have been added to the 
environment through human activities over the 
past two centuries. Tobacco smoke is one of the 
most important sources of cadmium exposure in 
the general population, and cadmium blood 
levels have been shown to increase by 
approximately 0.1-0.2 μg/l after smoking one 
cigarette. Environmental exposure to cadmium 
most commonly occurs in the form of chronic 
exposures via drinking water (1, 2). 
Cadmium exerts several toxic effects on humans 
and experimental animals; this substance mainly 
targets the kidneys, liver and the cardiovascular 
system (3). Several studies have reported a direct 
association between cadmium exposure and 
increased risk of bone fracture, renal dysfunction, 
hypertension and cancer (4). 
 
Furthermore, cadmium is a potent 
reproductive and developmental toxic agent; by 
crossing the placenta and entering the fetus, 
cadmium is able to cause a wide spectrum of 
deleterious effects on the reproductive system 
and fetal development.  
On the other hand, high doses of cadmium in 
animals could lead to congenital developmental 
disorders and fetal death accompanied by placental 
necrosis, while low-level exposure throughout 
gestation might result in retarded fetal growth and 
low birth weight (LBW) (2, 5).  
According to several experimental studies, 
cadmium toxicity results in numerous adverse 
effects during the prenatal period; for instance, 
cadmium exposure was observed to cause early 
onset of puberty and changes in the mammary gland 
of female offspring in rats. Moreover, cadmium 
exposure was found to affect immune system 
function during the prenatal period (6). 
Ebrahim K et al.                             Cadmium Toxicity and Low Birth Weight 
Iranian Journal of Neonatology 2015; 6(2):  2 
 
In a study by Siegers et al. (1983), cadmium 
concentration in amniotic fluids was determined in 
155 pregnant (smokers and non-smokers), and the 
obtained results indicated that cadmium 
concentration in the amniotic fluids of smoking 
pregnant women was approximately three times 
higher compared to non-smokers. Nevertheless, no 
correlation was observed between amniotic fluid 
cadmium levels and other factors such as age, week 
of gestation, blood pressure and pregnancy-induced 
complications (7). 
Hypertension is a relatively common medical 
complication during pregnancy, and preeclampsia is 
the most severe form of pregnancy-induced 
hypertension. Preeclampsia occurs in 7-10% of all 
pregnancies worldwide and is a major cause of 
maternal and prenatal mortality and morbidity. 
Cadmium intoxication is believed to induce 
hypertension, and several studies have indicated 
that pregnant humans and animals are 
comparatively more sensitive to the toxic effects of 
cadmium (1).  
In another study, Dawson et al. (1999) 
observed a significant increase in the cadmium 
levels of amniotic fluid in patients with 
preeclampsia (8). In addition, many studies have 
investigated the correlation between the placental 
and umbilical cord blood, mother’s whole blood 
level of cadmium and LBW of the neonate; 
however, adequate information is lacking  on the 
association between the cadmium levels of 
amniotic fluid and the risk of LBW (2, 9, 10).  
Tehran, the capital of Iran, is one of the most 
air-polluted cities in the world, and several 
surveys have reported high levels of cadmium 
exposure in the general population of this city 
(11). The present study aimed to investigate the 
association between cadmium levels of amniotic 
fluid and disorders such as preeclampsia, 
prematurity and the risk of LBW in five different 
public hospitals of Tehran. 
 
Method 
Subjects and Study Design  
This cohort study was conducted on 341 
pregnant women hospitalized in five public 
hospitals in Tehran from September 2011 to 
December 2012.  
All the subjects completed questionnaires 
including information about age, ethnic origin, 
employment status, smoking habits, dietary 
patterns, use of medications and number of 
previous pregnancies and childbirths.  
Other recorded data were the time of birth, 
weight and height of the neonates. Exclusion criteria 
were as follows: 1. pre-existing hypertension or 
history of preeclampsia; 2. liver, renal, 
cardiovascular or endocrine diseases; 3. use of 
nutritional supplements, diuretics, or receiving 
hormonal treatments. 
Furthermore, patients with severe disorders 
such as diabetes, epilepsy, renal disease and Rh-
factor disorders were excluded from the study. 
Written informed consent was provided from all 
the subjects prior to participation. 
Since the majority of reports on smoking 
pregnant women are ambiguous, and many of 
these women declare passive exposure to tobacco 
smoke, this parameter is determined through the 
assessment of plasma thiocyanate (SCN (-)) levels 
in pregnant women. According to the literature 
(12), patients with thiocyanate concentrations of 
<59 μM/L are considered as non-smokers, while 
those with thiocyanate concentrations of >60 
μM/L are defined as smokers. 
The clinical criteria to define a preeclamptic 
condition was A) systolic blood pressure >140 
mmHg and/or diastolic blood pressure >90 mmHg 
after 20th week of gestation, B) proteinuria >500 
mg per 24 hours.  Moreover, the birth weight of 
neonates was recorded and converted to a 
dichotomous measure of LBW (Yes/No) (<2500 g; 
LBW).  
Based on the cadmium concentration in the 
amniotic fluid, the subjects were divided into the 
following groups: 1. low exposure (1 µg/l), 2. 
moderate exposure (1-10 µg/l) and 3. high 
exposure (10 µg/l). Differences in the prevalence 
of LBW (<2500 g), preeclampsia and prematurity 
were also compared between these groups. 
 
Sampling 
Samples of amniotic fluids were provided from 
all the subjects for diagnostic purposes during 
childbirth and were properly labeled and stored at 
-20ºC until analysis. 
 
Measurement of Cadmium Concentration in 
Amniotic Fluids 
To determine cadmium concentrations, the 
samples were prepared via acid digestion for 
analysis, and 5 ml of 1:1 mixture of Per chloric 
acid (70%) and nitric acid (65%) were added to 1 
ml of amniotic fluids. Afterwards, the samples 
were heated until drying, reconstituted with nitric 
acid and distilled water, and analyzed using an 
atomic absorption spectrophotometer (AAS) 
(Model 4000, Perkin Elmer Corp, USA), which was 
equipped with a graphite furnace for the accurate 
measurement of cadmium. 
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All measurements were conducted in duplicate, 
and repeated measures were performed for 
suspicious results. 
 
Statistical analysis 
To examine the normal distribution of data, 
Shapiro-Wilk test was performed. If necessary, data 
were analyzed using non-parametric linear 
regression, Student’s t-test and one-way analysis of 
variance (ANOVA), as well as Dunnett’s test for 
multiple comparisons. The obtained values were 
expressed in Mean± Standard Error of the mean 
(SEM), and a P value of <0.05 was considered 
significant. All the statistical analyses in this study 
were performed using Graph Pad Prism 5© software. 
 
Results 
In total, 341 pregnant women with the mean 
age of 33.6±5.1 years were enrolled in this study. 
Approximately 83.2% of the studied subjects were 
within the age range of 20-35 years, 2% were 
under 18 years of age, and 9.7% were over 35 
years. In addition, the majority of the subjects 
(79.1%) were multiparous, and others (21.9%) 
were nulliparous.  
No significant difference was observed 
between multiparous and nulliparous patients in 
terms of the incidence of LBW, preeclampsia and 
prematurity (data not shown). Furthermore, other 
demographic features had no significant effects on 
the occurrence of LBW, preeclampsia and 
prematurity. In this study, all the patients had 
been residents of Tehran within the past three 
years, and no one had experienced occupational 
exposure to cadmium. 
For the measurement of cadmium 
concentration in amniotic fluids by AAS, limit of 
detection (LOD) and limit of quantification (LOQ) 
were estimated to be 28 ng/l and 71 ng/l, 
respectively; within-day and between-day and 
11.2%, respectively. In addition, the concentration 
of SCN (-) in 46 subjects was >59 coefficient of 
variation in this method were 8.5% therefore, 
these subjects were considered as smokers. 
The mean cadmium concentration of amniotic 
fluid in non-smokers (780± 0.231 ng/l) was 
significantly lower compared to smokers (13.4± 
0.91 µg/l). As shown in Figure 1, a significant 
correlation was observed between the amniotic 
fluid cadmium concentrations and SCN (-) levels in 
subjects with smoking habits (r2=0.882).  
Moreover, mean of birth weight in smokers 
and non-smokers was 3187±241 g and 3445±829 
g, respectively; however, no significant difference 
was observed between these two variables 
according to the student’s t-test (P<0.05).  
In the group of smoking mothers, 7 neonates 
(15.2%) and in the non-smoker group 37 
neonates (12.5%) had LBW (≤2500 g). The 
analysis of birth weight and amniotic fluid 
cadmium levels via non-parametric linear 
regression was indicative of a correlation between 
the reduction of birth weight and an increase in 
the cadmium levels of amniotic fluids (Figure 2). 
On the other hand, the prevalence of 
preeclampsia among the smoking mothers was 
26% (N=12), while it was 10.5% (N=31) among 
non-smokers, and a significant difference was 
observed between these two variables according 
to the student’s t-test (P<0.05).  
The total incidence rate of preeclampsia in all 
the subjects of this study was significantly higher 
(12.6%) than the results of similar studies in this 
regard. Moreover, no significant difference was 
observed in terms of the prevalence of 
prematurity between smokers and non-smokers 
in the present study. 
In this study, the subjects were divided into three 
groups based on the level of cadmium concentration 
in amniotic fluids, and the differences in the 
incidence of LBW (<2500 g), preeclampsia and 
prematurity were investigated using ANOVA. 
 
 
 
Figure 1. The correlation between amniotic fluid cadmium 
concentrations and plasma thiocyanate levels 
Figure 2. The relationship between birth weight and amniotic 
fluid cadmium levels. A significant decrease in birth weight 
with the increased levels of amniotic fluid cadmium can be 
observed 
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Table 1. Exposure status and its relations with incidence of low birth weight, preeclampsia and prematurity 
High (10 µg/l) Moderate (1-10 µg/l) Low (1 µg/l) Exposure status 
56 (16.4%) 173 (50.7%) 112 (32.8 %) Total number 
3102±752* 3311±424* 3531±426* Mean birth weight 
13* 
- (23.2% of cases in this group) 
-(30.9% of total low birth weight cases) 
18* 
- (10.4% of cases in this group) 
-(42.8% of total low birth weight cases) 
11 
- (9.8% of cases in this group) 
-(26.1% of total low birth weight cases) 
Number of low birth 
weight cases(≤2500g) 
12* 
- (21.4% of cases in this group) 
- (32.5% of total preeclamptic cases) 
20* 
- (11.5 % of cases in this group) 
- (46.5% of total preeclamptic cases) 
11 
- (9.8% of cases in this group) 
- (25.5% of total preeclamptic cases) 
Preeclamptic cases 
2 
(19% of total prematurity cases) 
5 
(45% of total prematurity cases) 
4 
(36% of total prematurity cases) 
Number ofprematurity 
cases 
* There is significant difference between groups, determined by ANOVA test, (P<0.05) 
 
As depicted in Table 1, the mean birth weight 
in each exposure group was significantly different 
from other exposure groups and an increase in 
exposure intensity lead to a reduction in the mean 
of birth weight. In addition, the incidence of LBW 
in the moderate- and high-exposure groups was 
significantly higher compared to the low-exposure 
group.  
Furthermore, 21.4% of the pregnant women in 
the high-exposure group were found to 
experience preeclamptic conditions during their 
pregnancy; this rate was significantly higher than 
the other exposure groups. However, no 
significant association was observed between the 
rate of prematurity and level of exposure in the 
three groups. 
 
Discussion 
Cadmium is a toxic metal, which is added to the 
environment through human activities such as 
combustion of fossil fuels, leach of landfill wastes 
and runoff from agricultural land and mining. 
Moreover, cadmium is a by-product of 
electroplating, manufacture of Nickel-cadmium 
batteries, pigments, stabilizers and alloys (3).  
Dietary intake of cadmium in European 
countries has been estimated to be between 10-
30µg per day (14); accordingly, consumption of 
certain foods such as shellfish, offal and rice could 
increase the risk of cadmium intake (15). Another 
significant human route of cadmium intake is 
smoking, with an estimated 0.2-1.0µg of cadmium 
per smoking one cigarette (16). 
Pregnancy is a critical period in terms of 
cadmium toxicity, and several adverse outcomes 
such as preeclampsia, LBW, prematurity, stillbirth 
and developmental effects have been attributed to 
acute, sub-acute and chronic cadmium exposure 
during pregnancy (3, 14, 17). Cadmium 
accumulates in the placenta interacting with the 
transport of micro-nutrients and may play a key 
role in the occurrence of intrauterine growth 
restriction (18).  
Furthermore, cadmium has been shown to 
inhibit the activity of 11-β-hydroxysteroid 
dehydrogenase enzyme, while decreasing 11-β-
HSD2 mRNA and protein in cultured human 
trophoblast cells. Reduced 11-β-HSD2 activity in 
the placenta is directly associated with the 
reduction of intrauterine growth (19). 
For the first time, Siegers et al. (1983) 
determined amniotic fluid cadmium levels in 155 
pregnant women (128 non-smokers and 27 
smokers). According to their findings, levels of 
cadmium concentration were noticeably higher in 
the amniotic fluids of smokers (mean: 7.29 ± 2.39 
µg/l) compared to non-smokers (mean: 2.58 ± 
1.36 ng/l).  
On the other hand, a significant correlation 
was observed between cadmium levels and daily 
consumption of cigarettes in the present study. 
These values were significantly higher in our 
study groups compared to previous studies in this 
regard (780± 0.231 ng/l in non-smokers vs. 12.4± 
0.91 µg/l in smokers).  
With respect to the findings of previous studies 
about environmental contamination of cadmium 
in Tehran and the daily uptake of this substance 
among the residents of this capital city (11, 20), 
the remarkable increase in the cadmium 
concentration of amniotic fluids of pregnant 
women was not unexpected.   
In one study, Menai et al. (2012) measured 
maternal blood cadmium levels in 901 women 
during pregnancy investigating the potential 
effects of maternal environmental cadmium 
exposure on the birth weight and fetal growth 
restriction of the neonates. According to their 
results, maternal cadmium levels were associated 
with LBW in the offspring of women with smoking 
habits during pregnancy.  
These findings confirmed the effects of 
cadmium toxicity on fetal growth through the 
probable accumulation and transition of this 
substance to the placenta (21). As previously 
mentioned, no significant difference was observed 
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between the mean of birth weight in smokers and 
non-smokers in the current study, which could be 
due to the small sample size of the smoker group, 
or the high variations in the birth weight of the 
neonates.  
One of the important findings regarding birth 
weight is that an increase in the cadmium levels of 
amniotic fluids could lead to a reduction in birth 
weight. In the present study, birth weight was 
below 2500 g in almost all the cases with amniotic 
fluid cadmium levels of >15 µg/l; therefore, it 
could be concluded that amniotic fluid cadmium 
levels of >15 µg/ml are significant risk factors for 
fetal growth and could considerably affect the 
pregnancy outcome. 
In another study, Dawson et al. (1999) 
demonstrated that amniotic fluid  levels of lead, 
calcium, magnesium, zinc and selenium between 
33-40 weeks of gestation could cause significant 
differences between normal and preeclamptic 
pregnancies (8).  
The observed changes in the levels of calcium 
and cadmium were consistent with the results of 
animal and human studies, in which sub-acute or 
chronic cadmium exposures were found to be 
associated with depression. The observed changes in 
the levels of calcium and cadmium were consistent 
with the results of animal and human studies, in 
which sub-acute or chronic cadmium exposures 
were found to be associated with calcium intake 
depression. Cadmium interference with calcium 
homeostasis and might results in physical 
syndromes such as to preeclampsia  (22, 23).  
In a study by Kosannovic et al. (2002), high 
concentrations of cadmium were detected in the 
umbilical cord blood and amniotic fluids of 
preeclamptic pregnant women (1); these findings 
were confirmed by several other studies (24).  
In the present study, a significant difference 
was observed in the incidence of preeclampsia 
between smokers and non-smokers; the total 
incidence rate in all the subjects was reported to 
be 12.6%, which was significantly higher than the 
rates reported in the normal population (7-10%). 
Moreover, it was indicated that 21.4% of the 
subjects in the high-exposure group (amniotic 
fluid cadmium levels of >10 µg/l) experienced 
preeclamptic conditions during their pregnancy, 
which was significantly different from other 
exposure groups and confirmed the pivotal role of 
cadmium toxicity in pregnancy-induced 
hypertension.  
Although several studies have been conducted 
on the effects of cadmium toxicity on pregnancy 
outcome (e.g. premature labor) (25, 26) no 
correlation was observed between the cadmium 
levels of amniotic fluids and rate of prematurity in 
the current study. 
 
Conclusion 
Amniotic fluid cadmium levels could be used as 
sensitive and reliable biomarkers of reproductive 
and developmental toxicity of cadmium. 
Therefore, determination of cadmium toxicity 
during pregnancy could predict the potential 
effects of this substance on fetal development and 
offer constructive solutions on environmental 
exposure control, quitting smoking and use of 
chelation therapy if necessary. 
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